Aratana Therapeutics

About:

Aratana Therapeutics develops innovative therapies for the animal health industry.

Website: https://www.aratana.com

Twitter/X: Aratana_PETX

Top Investors: Mid-America Angels, EASME - EU Executive Agency for SMEs, Kauffman Foundation, MPM Capital, Sandbox Industries

Description:

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.

Total Funding Amount:

$179M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Leawood, Kansas, United States

Founded Date:

2010-01-01

Founders:

Steven Peter

Number of Employees:

51-100

Last Funding Date:

2018-03-15

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai